Michael Erickson, PhD, to Succeed Jay Mazelsky as President and CEO; Mazelsky to Serve as Executive Chair of the Board of Directors “Mike’s appointment as the Company’s next President and CEO is the ...

Jan 13 (Reuters) - IDEXX Laboratories (IDXX.O), opens new tab on Tuesday named insider Michael Erickson as its next chief executive officer and said incumbent Jonathan Mazelsky will retire in 2027.

Shares of IDEXX Laboratories Inc. IDXX shed 1.48% to $714.04 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.19% to ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Jan 13 (Reuters) - IDEXX Laboratories on Tuesday named insider Michael Erickson as its next chief executive officer and said incumbent Jonathan Mazelsky will retire in 2027. The appointment will be ...

Achieves first quarter revenue growth of 4% as reported and 5% organic, supported by CAG Diagnostics recurring revenue growth of 3% as reported and 4.5% organic. Organic revenue growth supported by ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced two major advancements in veterinary cancer diagnostics: the expansion of its IDEXX Cancer Dx™ ...

Achieves third quarter revenue growth of 7% as reported and 6% organic, supported by CAG Diagnostics recurring revenue growth of 7% as reported and organic. Organic revenue growth supported by ...

The mogul, who's moving to the U.S., says "I think now is finally our moment" after the stars released their first full-length studio album. But at +175, a ball gown simply won't pay out. The ...

IDEXX Laboratories, Inc. (IDXX) is a multinational healthcare company specializing in the development, manufacture, and distribution of diagnostics and related products for companion animal veterinary ...